MVT-100
- Generic Name
- MVT-100
An Ascending Dose Comparison of MVT-100 to Definity in Healthy Volunteers
Phase 1
Completed
- Conditions
- Heart Diseases
- Interventions
- First Posted Date
- 2019-03-20
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Microvascular Therapeutics, LLC
- Target Recruit Count
- 16
- Registration Number
- NCT03882359
- Locations
- 🇺🇸
Saint Luke's Hospital of Kansas City, Kansas City, Missouri, United States
🇺🇸University of Nebraska Medical Center, Omaha, Nebraska, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath